Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Research Square|May 19, 2025
An integrated machine learning-based prognostic model in head and neck cancer using the systemic inflammatory response index and correlations with patient reported financial toxicityAnurag Singh, Sung Jun Ma, Dukagjin Blakaj, et al.
Molecular Carcinogenesis|June 16, 2017
Curcumin and metformin-mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cellsGangotri Siddappa, Safeena Kulsum, Doddathimmasandra Ramanjanappa Ravindra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2023
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic CancerAbigail C Cornwell, Arwen A Tisdale, Swati Venkat, et al.
Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.
BMC Cancer|June 21, 2023
Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiationBrian Yu, Sung Jun Ma, Michael Khan, et al.
JAMA Network Open|April 15, 2022
Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck CancerSung Jun Ma, Han Yu, Michael Khan, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Reversible therapeutic resistance in <i>EGFR</i> mutant lung cancer caused by <i>RB1</i> loss induced lineage plasticityLetian Zhang, Meenalakshmi Chinnam, Bradley Balk, et al.
Cancers|December 11, 2025
Development and External Validation of Integrated Machine Learning-Based Prognostic Model in Oropharyngeal Head and Neck Cancer Using the Systemic Inflammatory Response IndexAnurag K Singh, Sung Jun Ma, Dukagjin Blakaj, et al.
JAMA Network Open|June 27, 2023
Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapySung Jun Ma, Michael Khan, Udit Chatterjee, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
Pageof 10